ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
34.97
0.34%
US Tech 100
19,460.00
0.95%
S&P 500
5,509.01
0.62%
US Dollar vs CAD
1.36802
0.02%
Bitcoin
61,207.34
-1.32%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. ETFs
  4. UK
  5. LSE

  6. Ubsetf Sriw (SRIW) Share Price

Ubsetf Sriw

Ubsetf Sriw (SRIW)

LSE
1,593.40
-0.10
(-0.01%)
Closed July 02 10:30AM
Delayed by 15 minutes

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Key stats and details

Current Price
1,593.40
Bid
1,592.40
Ask
1,594.40
Volume
318
1,592.00 Day's Range 1,592.00
0.00 52 Week Range 0.00
Market Cap
310.835M
Previous Close
1,593.50
Open
1,592.00
Last Trade
318
@
1592
(AT)
Last Trade Time
Financial Volume
5,063p
VWAP
1,592.00
Average Volume (3m)
-
Shares Outstanding
7,472,000
Dividend Yield
-
PE Ratio
-6.67
Earnings Per Share (EPS)
-6.23
Revenue
90.35M
Net Profit
-46.58M

About Ubsetf Sriw

Sector
Real Estate Agents & Mgrs
Industry
Real Estate Div'd
Website
www.ubm-development.com
Headquarters
Vienna, Aut
Founded
1987
Ubsetf Sriw is listed in the Real Estate Agents & Mgrs sector of the London Stock Exchange with ticker SRIW. The last closing price for Ubsetf Sriw was 1,593.50p. Over the last year, Ubsetf Sriw shares have traded in a share price range of 0.00p to 0.00p.

Ubsetf Sriw currently has 7,472,000 shares outstanding. The market capitalization of Ubsetf Sriw is £310.84 million. Ubsetf Sriw has a price to earnings ratio (PE ratio) of -6.67.

SRIW Latest News

More News

UBS ETF MSCI WORLD SR (USD) Dis Net Asset Value(s)

UBS ETF MSCI WORLD SR (USD) Dis 02 July 2024   Fund UBS (Irl) ETF plc - S&P 500 ESG UCITS ETF - (USD) A-dis   ISIN Code IE00BK72HH44   Dealing Date 01/07/2024   NAV per Share 20.1504  ...

17 hours ago
RNS Regulatory News

UBS ETF MSCI WORLD SR (USD) Dis Net Asset Value(s)

UBS ETF MSCI WORLD SR (USD) Dis 01 July 2024   Fund UBS (Irl) ETF plc - S&P 500 ESG UCITS ETF - (USD) A-dis   ISIN Code IE00BK72HH44   Dealing Date 28/06/2024   NAV per Share 20.1669  ...

July 01 2024
RNS Regulatory News

UBS ETF MSCI WORLD SR (USD) Dis Net Asset Value(s)

UBS ETF MSCI WORLD SR (USD) Dis 28 June 2024   Fund UBS (Irl) ETF plc - S&P 500 ESG UCITS ETF - (USD) A-dis   ISIN Code IE00BK72HH44   Dealing Date 27/06/2024   NAV per Share 20.1699  ...

June 28 2024
RNS Regulatory News

UBS ETF MSCI WORLD SR (USD) Dis Net Asset Value(s)

UBS ETF MSCI WORLD SR (USD) Dis 27 June 2024   Fund UBS (Irl) ETF plc - S&P 500 ESG UCITS ETF - (USD) A-dis   ISIN Code IE00BK72HH44   Dealing Date 26/06/2024   NAV per Share 20.1236  ...

June 27 2024
RNS Regulatory News

UBS ETF MSCI WORLD SR (USD) Dis Net Asset Value(s)

UBS ETF MSCI WORLD SR (USD) Dis 26 June 2024   Fund UBS (Irl) ETF plc - S&P 500 ESG UCITS ETF - (USD) A-dis   ISIN Code IE00BK72HH44   Dealing Date 25/06/2024   NAV per Share 20.1503  ...

June 26 2024
RNS Regulatory News

UBS ETF MSCI WORLD SR (USD) Dis Net Asset Value(s)

UBS ETF MSCI WORLD SR (USD) Dis 25 June 2024   Fund UBS (Irl) ETF plc - S&P 500 ESG UCITS ETF - (USD) A-dis ISIN Code IE00BK72HH44 Dealing Date 24/06/2024 NAV per Share 20.0732 Base...

June 25 2024
RNS Regulatory News

UBS ETF MSCI WORLD SR (USD) Dis Net Asset Value(s)

UBS ETF MSCI WORLD SR (USD) Dis 24 June 2024   Fund UBS (Irl) ETF plc - S&P 500 ESG UCITS ETF - (USD) A-dis ISIN Code IE00BK72HH44 Dealing Date 21/06/2024 NAV per Share 20.1245 Base...

June 24 2024
RNS Regulatory News

UBS ETF MSCI WORLD SR (USD) Dis Net Asset Value(s)

UBS ETF MSCI WORLD SR (USD) Dis 21 June 2024   Fund UBS (Irl) ETF plc - S&P 500 ESG UCITS ETF - (USD) A-dis   ISIN Code IE00BK72HH44   Dealing Date 20/06/2024   NAV per Share 20.1588  ...

June 21 2024
RNS Regulatory News
Period †ChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000SP
40000000SP
120000000SP
260000000SP
520000000SP
1560000000SP
2600000000SP

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
LPENLoop Energy Inc
$ 0.04
(60.00%)
46.79k
DYADynaCERT Inc
$ 0.23
(53.33%)
2.98M
SMCSulliden Mining Capital Inc
$ 0.015
(50.00%)
200k
IVQInvesque Inc
$ 0.18
(20.00%)
9k
WCM.AWilmington Capital Management
$ 3.30
(17.86%)
400
CWEBCharlottes Web Holdings Inc
$ 0.20
(-25.93%)
433.17k
VGCXVictoria Gold Corp
$ 0.84
(-20.75%)
3.57M
AREAecon Group Inc
$ 13.99
(-17.61%)
1.53M
FLOWFlow Beverage Corp
$ 0.19
(-13.64%)
12.15k
PEAPieridae Energy Limited
$ 0.34
(-12.82%)
277.08k
TDToronto Dominion Bank
$ 75.59
(0.52%)
19.59M
TRPTC Energy Corporation
$ 51.59
(-0.52%)
15.7M
CMCanadian Imperial Bank of Commerce
$ 65.64
(0.91%)
11.98M
BNSBank of Nova Scotia
$ 62.62
(0.06%)
11.23M
CNQCanadian Natural Resources Ltd
$ 49.27
(1.11%)
10.61M

Discussion

View Full Feed
Kutter Kutter 3 minutes ago
BooHoo! You're one to talk. The election is over! Deal with it! CryBaby 😢 😂 Biden is you're Daddy!!!
DJT
janice shell janice shell 3 minutes ago
Ozempic can now be prescribed for weigh loss. But now we have Wegovy, Zepbound, and more. You can also get generic semaglutide online.

It all seems to have nasty side effects for some people, but apparently it does work. It isn't "just an appetite suppressant".
BADALI BADALI 3 minutes ago
Go buy at ask tomorrow .
SMCE
k9uwa k9uwa 4 minutes ago
This last sentence looks like an invitation to ANAVEX to file NDA pronto. The MAB they approved today is anything but safe.

"FDA Roundup: July 2, 2024
. Today’s approval is evidence of the FDA’s commitment to helping more safe and effective drugs to treat Alzheimer’s disease b
AVXL
BADALI BADALI 4 minutes ago
No one is scaring you and you can buy at ask tomorrow and take this above penny.
I will be happy but I will add only lower pps
SMCE
BERKSHIRE AGENT BERKSHIRE AGENT 5 minutes ago
Wow I just came back to check and we had a strong close! This is setting up for a MEGA breakout indeed ;)
HMLA
r clarke r clarke 5 minutes ago
Fraud investigations, CEO and COO turnover

Whats going on, I thought this was a decent company?
MEI
XMaster2023 XMaster2023 6 minutes ago
Yes you are a Legend in your own mind. The Market Makers were playing the odds shorting NWBO as over 3000 rGBM trials have failed before it. I really can’t blame them, but they failed. Then instead of admitting they screwed up, they doubled down like all rich pricks today. They will get what the
NWBO
vein vein 6 minutes ago
Thank you !!
LWLG
fuagf fuagf 6 minutes ago
Seems no doubt the legal minds of at least Alito and Thomas
are being subverted by ideology and worldly pleasures.
BADALI BADALI 7 minutes ago
You have zero clue. I will add more.
SMCE
DrHigh DrHigh 7 minutes ago
I dont care all that much for some of his antics so I am not Bigger apologist but he is at least a real person and not living some made up life online claiming to have been some big shot CEO who has 30 securities lawyers on retainer. Enjoy your delusions.
NWBO
PurpleCritter2001 PurpleCritter2001 8 minutes ago
No disrespect Vein, but it is in the realm of possibility that Lightmatter could now or in the future want or need Lightwave.

LightWave is generally an ENABLING technology to Photonics. The more one understands about the underlying technology and how it may fit in the overall eco
LWLG
fuagf fuagf 9 minutes ago
The right result is what matters.
123P654 123P654 9 minutes ago
LET'S GO ROGER "ROBIN" HOOD!!

https://investorshub.advfn.com/uimage/uploads/2024/7/2/mzhtnHeadbang.gif
BLLB
r clarke r clarke 9 minutes ago
HIMS selling compounded GLP-1 despite the FDA warnings.
Compounding is allowed during shortages, but there may be issues with supplier?
Compounded drug is not FDA tested or approved.
Possible short candidate if it heads higher?
GLP
drugrunner drugrunner 9 minutes ago
I guess u sold your stock BB.. ??
NWBO
JNdouble1 JNdouble1 9 minutes ago
A different approach:

Here’s a hypothetical. What if BIEL decided to change manufacturers. Maybe make the device here in the states for example.

Now the new manufacturer would need to be registered with and inspected by the FDA.

Ok, so what would BIEL h
BIEL
yman yman 10 minutes ago
Jon Jon: Pretty sure the original application was filed in 2021. Since then they amended it and now that needs reviewed. You can follow the history on Espacenet patent search. Search rapid viral assay.
NNLX
boston745 boston745 10 minutes ago
Tomorrow no, that target is off. First ARK needs to start selling shares and SpaceX offering close. Thats when this should start heading to that target.
TSLA
I ll be back I ll be back 10 minutes ago
Spot on!

Rig has a huge following. There will be plenty of eyes watching. And hopefully buying, if they like what they see. But keep in mind, there's a 3 day w/e, and market closes early at 1:00 tomorrow, so hope next week will heat up.

Putting more eyes on an OTC that
GME
Warren Buffet wantabe Warren Buffet wantabe 11 minutes ago
Well down to the key time.

If the insiders stop selling this stock could run to $.05-$1.0 a share before the trial.

I would expect a settlement before the trial. Question is what amount. Hope it’s significant. If this starts running I will register my shares in July
VPLM
skyrocketinsight skyrocketinsight 11 minutes ago
I was also thinking of a word THAT DESCRIBED MARK started with L AND ENED WITH AN R (LOSER)
L***R
L***R
L***R
MIKP
drugrunner drugrunner 12 minutes ago
We are all nobodies BB..

none better than the rest

NWBO
demonsmith demonsmith 13 minutes ago
Tom probably kick it up to 60 percent of daily vol for dumping shares
GTVH

Your Recent History

LSE
SRIW
Ubsetf Sriw
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved